Add BrightSurf on Google Email

Science News for June 29, 1998


A Synthetic Peptide Destroys Brain Plaque Implicated in Alzheimer's Disease

Scientists have created a synthetic peptide that blocks the formation of amyloid plaques in the brain, destroying existing plaques and preventing nerve cell death. This breakthrough may lead to a new therapy for Alzheimer's disease and other diseases caused by defective protein folding.

SourceNYU Langone Health / NYU Grossman School of Medicine·JournalNature Medicine·DateJun 29, 1998

Scientific Panel Concludes Some UFO Evidence Worthy Of Study

A panel of scientists concludes that some UFO sightings are accompanied by physical evidence deserving scientific study. While the panel was not convinced of an extraterrestrial explanation, it highlighted potential health risks and noted that rare natural phenomena can cause similar effects.

SourceStanford University·JournalJournal of Scientific Exploration·DateJun 29, 1998
GoPro HERO13 Black

GoPro HERO13 Black records stabilized 5.3K video for instrument deployments, field notes, and outreach, even in harsh weather and underwater conditions.

Platelet Receptor Biology Is Key To Fighting Heart Disease

A team of researchers led by Dr. Joel Bennett has successfully developed a new technique to study the IIb/IIIa receptor, a key player in platelet aggregation. This breakthrough could pave the way for the creation of more potent anti-clotting drugs.

SourceUniversity of Pennsylvania School of Medicine·JournalJournal of Biological Chemistry·DateJun 29, 1998

Voluntary HIV Counseling And Testing Reduce Risk Behavior In Developing Countries

Research finds that voluntary HIV counseling and testing significantly reduce risk behaviors, including unprotected sex, in individuals and couples. The study, conducted in three developing countries, shows a 50% reduction in risk behavior among participants who received counseling and testing compared to those receiving standard healt...

SourceUniversity of California - San Francisco·DateJun 29, 1998

Multi-Center Study Provides Guidelines For Genetic Testing In Women With Breast Cancer: BRCA Abnormalities Multiply Risk Of Ovarian Cancer

A multi-center study provides clear guidelines for genetic testing in women with breast cancer, identifying those at high risk of ovarian cancer. The study found that nearly 40% of participants had abnormalities in BRCA1 and BRCA2 genes, associated with a 10-fold increase in ovarian cancer risk.

SourceUniversity of Chicago Medical Center·JournalJournal of Clinical Oncology·DateJun 29, 1998